E7 TCR-T cell induction therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for E7 TCR-T cell induction therapy, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers [Phase 1, Phase 2]